0244: A Phase II Study of Two Different Induction Regimens of High Dose Carboplatin (Hdc) Vs Weekly Paclitaxel/Gemcitabine (Wpg) Followed By Pacli-Taxel/Carboplatin/Gemcitabine (Pcg) in Advanced Ovarian Cancer (Aoc)
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0244: A Phase II Study of Two Different Induction Regimens of High Dose Carboplatin (Hdc) Vs Weekly Paclitaxel/Gemcitabine (Wpg) Followed By Pacli-Taxel/Carboplatin/Gemcitabine (Pcg) in Advanced Ovarian Cancer (Aoc)
